Mark Wilterding - 12 Jan 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Jan 2026, 16:14:59 UTC
Prior SEC filing
30 Jan 2026
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bridget Balisy, as Attorney-in-Fact

Key filing fact

Mark Wilterding filed Form 4 for RxSight, Inc. (RXST) on 30 Jan 2026.

Key facts

  • This page summarizes Mark Wilterding's Form 4 filing for RxSight, Inc. (RXST).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 30 Jan 2026, 16:14.

Change

  • Previous filing in this sequence was filed on 30 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107187 Primary reporting owner

Wilterding Mark

Relationship
Chief Financial Officer
Address
100 COLUMBIA, ALISO VIEJO
Signature
/s/ Bridget Balisy, as Attorney-in-Fact
Signature date
30 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+258,770
Change %
Price
$0.000000
Shares after
258,770
Date
12 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
258,770
Exercise price
$10.09
Footnotes
F1
RXST transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+163,528
Change %
Price
$0.000000
Shares after
163,528
Date
12 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
163,528
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.

Footnote F2

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award will vest on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .